The expression of selected metalloproteinases and tissue inhibitors of metalloproteinases (TIMP) was examined in three squamous cell carcinoma (SCC) cell lines (FaDu, SiHa, A431) and a keratinocyte cell line (HaCaT) to determine which metalloproteinases function in SCC invasiveness. A Matrigel invasion assay was used to assess invasiveness of the cell lines. Only the FaDu cell line showed invasiveness in this assay, and invasion of Matrigel by FaDu cells was inhibited by treatment with the metalloproteinase inhibitor, batimastat. No correlation was found between mRNA expression for matrilysin, stromelysins 1±3, TIMP-1, or TIMP-3 and secretion of these proteins, indicating that the extracellular activity of these molecules is regulated post-transcriptionally. The SCC cell lines differed from the HaCaT line in that matrilysin and TIMP-1 proteins were detected in conditioned medium from all SCC cell lines, but not in medium from HaCaT cells. Only the invasive cell line, FaDu, released active stromelysin-1 into the culture medium. These results indicate that while matrilysin contributes to the invasive phenotype, activation of stromelysin-1 is a key regulatory step for invasiveness in SCC cells. Key words: batimastat/ invasion/Matrigel/metalloproteinase/tumorigenesis. J Invest Dermatol 118: 759±766, 2002 I n order to migrate into the stroma, invade other tissues, and metastasize, epithelioid tumor cells must digest and migrate through their basal lamina and then pass through the extracellular matrix of surrounding stromal tissue (Woodhouse et al, 1997) . Proteolysis of the basal lamina and extracellular matrix results from the action of metalloproteinases produced by both tumor cells and surrounding stromal cells (Kleiner and Stetler-Stevenson, 1999) . Gene transfer experiments have consistently shown that increased metalloproteinase activity is associated with increased invasiveness of tumor cells (reviewed in Knox et al, 1998) , but metalloproteinases have also been shown to affect cell proliferation and tumorigenesis (Meade-Tollin et al, 1998; Boulay et al, 2001) . Consequently, inhibitors of metalloproteinases are being tested for their therapeutic effects on tumor development, growth, invasiveness, and metastasis.
The expression of selected metalloproteinases and tissue inhibitors of metalloproteinases (TIMP) was examined in three squamous cell carcinoma (SCC) cell lines (FaDu, SiHa, A431) and a keratinocyte cell line (HaCaT) to determine which metalloproteinases function in SCC invasiveness. A Matrigel invasion assay was used to assess invasiveness of the cell lines. Only the FaDu cell line showed invasiveness in this assay, and invasion of Matrigel by FaDu cells was inhibited by treatment with the metalloproteinase inhibitor, batimastat. No correlation was found between mRNA expression for matrilysin, stromelysins 1±3, TIMP-1, or TIMP-3 and secretion of these proteins, indicating that the extracellular activity of these molecules is regulated post-transcriptionally. The SCC cell lines differed from the HaCaT line in that matrilysin and TIMP-1 proteins were detected in conditioned medium from all SCC cell lines, but not in medium from HaCaT cells. Only the invasive cell line, FaDu, released active stromelysin-1 into the culture medium. These results indicate that while matrilysin contributes to the invasive phenotype, activation of stromelysin-1 is a key regulatory step for invasiveness in SCC cells. Key words: batimastat/ invasion/Matrigel/metalloproteinase/tumorigenesis. J Invest Dermatol 118: 759±766, 2002 I n order to migrate into the stroma, invade other tissues, and metastasize, epithelioid tumor cells must digest and migrate through their basal lamina and then pass through the extracellular matrix of surrounding stromal tissue (Woodhouse et al, 1997) . Proteolysis of the basal lamina and extracellular matrix results from the action of metalloproteinases produced by both tumor cells and surrounding stromal cells (Kleiner and Stetler-Stevenson, 1999) . Gene transfer experiments have consistently shown that increased metalloproteinase activity is associated with increased invasiveness of tumor cells (reviewed in Knox et al, 1998) , but metalloproteinases have also been shown to affect cell proliferation and tumorigenesis (Meade-Tollin et al, 1998; Boulay et al, 2001) . Consequently, inhibitors of metalloproteinases are being tested for their therapeutic effects on tumor development, growth, invasiveness, and metastasis.
Batimastat is a general matrix-metalloproteinase inhibitor that suppresses extracellular matrix degradation in vitro and reduces the growth of solid tumors in mice (Rasmussen and McCann, 1997) . Batimastat resembles metalloproteinase substrates and acts by competitive inhibition of metalloproteinase activity, but has no effect on metalloproteinase expression, cell viability, or cell proliferation (Chirivi et al, 1994; Sledge et al, 1995; Rasmussen and McCann, 1997) . Batimastat treatment has been shown to signi®cantly reduce invasiveness of malignant human glioma cells (Tonn et al, 1999) and neoplastic human prostate cells (Knox et al, 1998) in Matrigel invasion assays. Studies on mouse models have demonstrated that Batimastat also reduces the incidence of intestinal tumors (Heppner-Goss et al, 1998) , inhibits metastasis of human breast cancer cells (Sledge et al, 1995) , reduces tumor growth and enhances survival in mice bearing human ovarian tumor grafts (Davies et al, 1993) , and prevents metastasis of human pancreatic cancer xenografts (Rasmussen and McCann, 1997) . Research on prostate tumors and pancreatic xenografts indicates that metalloproteinase inhibition by batimastat allows tumor cells to reform a basal lamina, thereby limiting invasiveness (Rasmussen and McCann, 1997; Knox et al, 1998) . The effects of batimastat on squamous cell carcinoma (SCC) have not been described.
Expression of the metalloproteinase matrilysin (MMP-7) is not found in epidermal or stromal cells in normal skin, but in skin cancer, matrilysin is expressed by tumor cells at the stromal interface in SCC, and in aggressive and recurrent morpheaform and in®ltrative basal cell carcinomas (BCC). Nodulocystic, keratotic, and adenoid BCC, which are not invasive, do not express matrilysin (Karelina et al, 1994) . Matrilysin is released from the cell as an inactive proenzyme that is cleaved to yield an active protein (Woessner, 1991) . In addition, transformation of HaCaT ± a nontumorigenic, noninvasive, keratinocyte cell line ± with cras
Ha gives rise to tumorigenic cells with increased expression and secretion of promatrilysin (Meade-Tollin et al, 1998) .
Another family of metalloproteinases, the stromelysins, promote tumor growth through different mechanisms. Stromelysin-1 (MMP-3) digests extracellular matrix proteins and cleaves promatrilysin, releasing active matrilysin Tsukifuji et al, 1999) . Like matrilysin, stromelysin-1 is not expressed by keratinocytes in normal skin, but is highly expressed in SCC, and is expressed by keratinocytes after wounding (Muller et al, 1991; Saarialho-Kere et al, 1994; Kusukawa et al, 1996; Tsukifuji et al, 1999) . Stromelysin-2 (MMP-10) is synthesized by SCC cells, but is associated with in¯ammation and wound healing rather than invasiveness (Kerkela È et al, 2001; Madlener et al, 1996) . Stromelysin-3 (MMP-11) does not digest extracellular matrix. Instead of stimulating invasiveness through matrix degradation, stromelysin-3 inhibits cell death in malignant cells, thus promoting tumor growth (Noe Èl et al, 2000; Boulay et al, 2001) .
Metalloproteinase activity is inhibited by the tissue inhibitors of metalloproteinases (TIMP) (Kleiner and Stetler-Stevenson, 1999) . TIMP proteins bind metalloproteinases with 1:1 stoichiometry and form noncovalent complexes (Umenishi et al, 1991; Gomis-Ruth et al, 1997) . TIMP binding not only inhibits the activity of active metalloproteinases, but also suppresses conversion of pro-metalloproteinase molecules to their active forms (Umenishi et al, 1991) . In normal skin, TIMP-3 and matrilysin exhibit the same patterns of expression, suggesting that TIMP-3 regulates matrilysin activity in skin (Airola et al, 1998) .
This study was performed to determine whether Batimastat inhibits invasiveness in SCC cells and to determine which metalloproteinases regulate invasiveness in SCC cells.
MATERIALS AND METHODS

Cell culture
Cell lines used in this study were HaCaT, an immortalized, nontumorigenic keratinocyte cell line (Boukamp et al, 1988 (Boukamp et al, , 1990 ; SiHa, a SCC from the cervix (ATCC HTB-35, American Type Culture Collection, Rockville, MD); FaDu, a SCC from the pharynx (ATCC HTB-43); and A431, a metastatic SCC from the epidermis (ATCC CRL-1555). Each cell line was maintained in D-MEM/F-12 medium (Gibco-BRL, Grand Island, NY) containing 3% fetal bovine serum (Gibco-BRL), 80 units penicillin per ml, and 80 mg streptomycin per ml (Gibco-BRL). Cultures were grown in a humidi®ed incubator at 37°C, 5% CO 2 in air.
Matrigel invasion assay
The invasion assay was adapted from the method described by Kawahara et al (1995) . Chambers were prepared for invasion assays by coating porous (8 mm pores) tissue culture inserts (Falcon, Franklin Lakes, NJ) with 90 mg per cm 2 of Matrigel (Becton Dickinson Labware, Bedford, MA) suspended in phosphate-buffered saline (PBS; Sigma, St. Louis, MO). Inserts were placed in a 24 well plate containing medium with 10% fetal bovine serum, which stimulates cell migration. Cells were plated on the inserts at 5 Q 10 4 cells per insert in serum-free medium. For control experiments, cells were plated in serum-free medium on inserts that were not coated with Matrigel. Cells were incubated for 24 h, then ®xed and stained with Diff-Quick (Dade Behring, Newark, DE). Each assay was performed in triplicate. For each cell line the number of cells passing through uncoated and Matrigelcoated ®lters were counted. Cells on each insert were viewed with a Zeiss Axioscop microscope, and counted in 30 optical ®elds (2.5 Q 2.5 mm grid) at 40Q magni®cation. Statistical signi®cance was determined using a one-tailed t-test for samples of unequal variance.
To assess the effects of Batimastat (BB-94, British Biotech Pharmaceuticals, Oxford, U.K.) on invasion of Matrigel, cells were plated on inserts in serum-free medium containing 0.1 or 1.0 mM Batismastat and incubated for 24 h before counting as described.
Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from cells using the Qiagen RNeasy kit (Valencia, CA). RNA 100 ng was ampli®ed by RT-PCR, using the Titan kit (Roche Biochemicals, Indianapolis, IN). The RT-PCR program was as follows: one cycle of 50°C for 30 min, 90°C for 2 min; 15 cycles of 90°C for 1 min, 55°C for 30 min, 68°C for 1 min; 10 cycles of 90°C for 1 min, 58°C for 30 min, 68°C for 1 min; one cycle of 68°C for 4 min. Primers for human matrilysin were 5¢-GAACAATTGTCTCTGGACGG and 3¢-TTGGCTTCTACTGTT-GGC. Primers for human TIMP-1 were 5¢-GACTCTTGCACATCAC-TAC and 3¢-ACACTGTGCAGGCTTCAGT. Primers speci®c for human TIMP-3 were 5¢-AATGACCCCTTGGCTCGG and 3¢GGT-GTAGACCAGCGTGCC. Primers for human stromelysin-1 were 5¢-AAGAGCAACGACGAGTACTT and 3¢-AGGTCCTTGCTAGTAA-CTTCA. Human stromelysin-2 primers were 5¢-AGCTAGACACT-GACACTCTG and 3¢-TGCCTGATGCATCTTCTGTC. Human stromelysin-3 primers were 5¢-TCGACTATGATGAGACCTG and 3¢-CAGTCTGAGACAGTCGCTG. RT-PCR products were separated on a 2% SeaKem agarose gel (FMC, Rockland, ME), detected with Sybr Green I (FMC) and analyzed with a FluoroImager (Molecular Dynamics, Sunnyvale, CA). Semiquantitative evaluation of expression was performed by comparison with expression of the GADPH gene in the same sample. Primers for human GAPDH were 5¢-ACAGTCCA-TGCCATCACTGCC and 3¢-GCCTGCTTCACCACCTTCTTG.
Immunoblotting
Levels of metalloproteinase and TIMP proteins were analyzed in conditioned medium by immunoblotting. For conditioned medium samples, each cell line was grown in serum-free medium for 48 h. The culture medium was then collected, concentrated 10-fold with Millipore Ultrafree-probind membrane ®lters (Millipore, Bedford, MA) , and stored at ±80°C. For each sample, 30 mg of protein was loaded onto a 4%±20% gradient SDS-polyacrylamide gel (FMC) in reducing buffer (Laemmli buffer, Bio-Rad Laboratories, Hercules, CA) and electrophoresed at 70 V. Colored molecular weight markers (Rainbow markers, Amersham-Pharmacia, Piscataway, NJ) were run on each gel. The proteins were transferred to Immobilon-P membrane (Millipore) for immunostaining. Membranes were blocked for 1 h at room temperature with 10% fat free milk in TBS (20 mM Tris, 150 mM NaCl, pH 7.4) containing 0.1% Tween-20, then incubated for 90 min with primary antibody diluted in TBS-0.1% Tween-20. After washing, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody (Amersham-Pharmacia) for 45 min. Antibody binding was detected using enhanced chemiluminescence (AmershamPharmacia).
Immunocytochemistry
To synchronize the cell cultures for mitosis, all cell lines were treated with 4.0 mg aphidicolin per ml for 8 h. Medium was then replaced to wash out the aphidicolin and cells were ®xed for immunocytochemistry at 2, 4, 8, 12, 16, and 24 h after removal of aphidicolin. For antibody labeling, cells were ®xed with icecold 50% acetone in methanol, washed with PBS, washed twice with 5% bovine serum albumin in PBS, then incubated with primary antibodies at 4°C overnight. Samples were washed three times with 0.5% bovine serum albumin in PBS, then incubated with secondary antibodies for 1 h at room temperature. After washing, DNA was stained with 100 ng DAPI (4,6-diamidino-2-phenylindole) per ml (Sigma). DNA staining was used to identify mitotic cells.
All primary antibodies for immunoblotting and immunocytochemistry were mouse monoclonal antibodies obtained from Oncogene Research Products (Boston, MA). Speci®cally, these were IM40T, MMP-7 (Ab-1) speci®c for promatrilysin; IM47T, MMP-7 (Ab-2) speci®c for active matrilysin; IM69T, MMP-3 (Ab-4) speci®c for pro-and active stromelysin-1; IM75T, MMP-10 (Ab-2) speci®c for pro-and active stromelysin-2; IM86T, MMP-11 (Ab-2) speci®c for pro-and active MMP-11; IM68T, MMP-2 (Ab-8) speci®c for pro-and active gelatinase A; IM37T, MMP-9 (Ab-3) speci®c for pro-and active gelatinase B; IM63T, TIMP-1 (Ab-4); IM82T, TIMP-2 (Ab-4); IM43T, TIMP-3 (Ab-1). Secondary antibodies for immunocytochemistry were conjugated with Texas Red or FITC and obtained from Jackson ImmunoResearch Laboratories (West Grove, PA).
RESULTS
Invasion assays were performed to determine whether cell invasiveness correlates with the production of matrilysin or other metalloproteinases. Invasiveness was measured as the ability of cells to digest Matrigel. The four cell lines differed in ability to pass through uncoated ®lters, indicating inherent differences in cell mobility (Fig 1a) . The number of FaDu cells passing through uncoated ®lters was signi®cantly (p < 0.05) greater than the number of HaCaT cells crossing uncoated ®lters. HaCaT and SiHa cell lines exhibited both poor cell mobility and Matrigel invasion. A431 cells demonstrated greater mobility and Matrigel invasion than HaCaT and SiHa cells, although assay results did not reach statistical signi®cance.
Treatment with the inhibitor Batimastat at 0.1 mM reduced by half the mean number of FaDu or HaCaT cells passing through uncoated ®lters (Fig 1a) . Treatment with 1.0 mM Batimastat reduced by at least half the number of HaCaT, FaDu, or A431 cells traversing uncoated ®lters, but mobility of treated cells was signi®cantly different from untreated cells only in the HaCaT cell line (Fig 1a) . Batimastat treatment had no effect on the mobility of SiHa cells (Fig 1a) . On Matrigel-coated ®lters, both FaDu and A431 cells were active in digesting Matrigel; however, FaDu cells were four times more active than A431 in invading the Matrigel (Fig 1b) . The number of FaDu cells traversing Matrigel-coated ®lters was signi®cantly (p < 0.05) greater than the number of HaCaT cells passing through the Matrigel. HaCaT and SiHa showed only weak invasion of Matrigel (Fig 1b) . Batimastat at 1.0 mM signi®cantly inhibited Matrigel invasion by FaDu cells (Fig 1b) . These results show that the FaDu cell line is the only SCC line tested that readily invades Matrigel, and that inhibition of metalloproteinase activity inhibits Matrigel invasion by FaDu cells.
To determine if invasiveness and expression of metalloproteinase or TIMP mRNA are correlated, steady-state levels of mRNA for matrilysin, stromelysins-1, 2, and 3, and TIMP-1 and -3 in each cell line were measured by semiquantitative RT-PCR. These results are shown in Fig 2. Only mRNA for stromelysin-2 was higher in the FaDu cell line than in the other cell types, and the difference was not substantial. The four cell lines expressed similar levels of mRNA for matrilysin, stromelysin-3, and TIMP-1 (Figs 2a, b) . Stromelysin-2 mRNA was the most abundantly expressed stromelysin RNA in all four cell lines (Fig 2a) . TIMP-3 mRNA levels were nearly 2-fold greater in HaCaT and A431 cells than in SiHa or FaDu cells (Fig 2c) . These results do not reveal a clear correlation between invasiveness in Matrigel and steady-state RNA levels for matrilysin, stromelysins-1±3, or TIMP-1 or -3.
Immunoblotting was performed to examine the levels of metalloproteinases and TIMP released into the culture medium by each cell line. These results are shown in Fig 3. Conditioned medium from FaDu and A431, the cell lines with greatest mobility, contained the highest amounts of both promatrilysin and active matrilysin. Both forms were present in lesser amounts in medium from SiHa cells, but neither form was detected in conditioned medium from HaCaT cells. A similar pattern was seen for TIMP-1: FaDu and A431 cells produced the greatest amounts of TIMP-1, SiHa cells produced a lesser amount, and no TIMP-1 was detected in medium from HaCaT cells. Neither TIMP-2 nor TIMP-3 could be detected in conditioned medium from any of the cell lines. These results suggest that TIMP-1 regulates the activity of secreted matrilysin in these cell lines.
FaDu and A431 medium also contained the highest amounts of prostromelysin-1, but only medium from FaDu cells contained a substantial level of active stromelysin-1. FaDu cells also produced greater amounts of active stromelysin-2 and active stromelysin-3 than the other three cell lines. Stromelysin 2 was easily detected in medium from HaCaT and A431 cells, but only weakly detectable in medium from SiHa cells. Stromelysin 3 was weak in HaCaT, SiHa, and A431 cell medium. Medium from FaDu and A431 cells contained the highest amounts of active gelatinase A, but strong labeling for gelatinase A was also seen in SiHa and HaCaT cells. In contrast, active gelatinase B (MMP-9) was clearly present in medium from HaCaT and SiHa cells, the cell lines with poor mobility, but was barely detectable in medium from FaDu and A431 cells. Thus, only secretion of active stromelysin-1 and stromelysin-3 correlates with the invasive phenotype exhibited by the FaDu cell line, whereas gelatinase A and matrilysin secretion is associated with cell mobility and the SCC phenotype.
Cellular expression of active matrilysin re¯ected the release of matrilysin into culture medium. Antibody labeling revealed little or no active matrilysin in HaCaT cells, except in mitotic cells (Fig 4a) . In contrast, SiHa, FaDu, and A431 cells were strongly labeled for active matrilysin in nondividing and mitotic cells (Figs 4b±d) . In all cell lines, labeling for active matrilysin was localized around the perimeter of the nucleus and may be associated with the endoplasmic reticulum. Stromelysin-1 labeling was similarly greater in the SCC lines than in HaCaT cells, and exhibited the same cellular localization as matrilysin (Fig 5) . Although TIMP-1 was not found in medium from HaCaT cells, cell-associated TIMP-1 was detected by antibody labeling in HaCaT cells, as well as in the three SCC cell lines (Fig 6) . TIMP-1 labeling was greatest in A431 cells (Fig 6d) . In the three SCC cell lines, TIMP-1 labeling was concentrated around the nuclear perimeter ( Figs 6b±d) ; however, in HaCaT cells, nuclei were brightly labeled (Fig 6a) . Labelling for matrilysin, stromelysin-1, and TIMP-1 in all four cell lines appeared more intense in mitotic cells. 
DISCUSSION
Metalloproteinases have been shown to promote tumor progression through several mechanisms (reviewed in Kleiner and StetlerStevenson, 1999; Sternlicht et al, 2000) . Increased metalloproteinase activity increases tumor cell invasiveness through extracellular matrix (Knox et al, 1998) , and treatment with TIMP inhibits both metalloproteinase activity and invasiveness (Umenishi et al, 1991; DeClerck et al, 1992; Liu et al, 1997) ; however, at least one metalloproteinase, stromelysin-3, does not digest matrix, but promotes tumor growth by blocking cell death in malignant cells (Boulay et al, 2001) . Matrilysin and gelatinase A are thought to play a role in tumor initiation rather than invasiveness (Meade-Tollin et al, 1998) . Metalloproteinase degradation of extracellular matrix may release matrix-associated growth factors that stimulate tumor cell proliferation (Vlodavsky et al, 1990) . Conversely, contact with particular matrix proteins can suppress tumor cell proliferation, which is enhanced when these matrix components are degraded (Henriet et al, 1999) . Additionally, matrilysin and stromelysin-1 can cleave E-cadherin, thereby increasing tumor cell invasiveness by blocking cell adhesion (Noe È et al, 2000) .
In normal cells and tissues, metalloproteinases also carry out routine tasks such as matrix repair and remodeling, but few metalloproteinases are associated with unique functions, and most participate in similar tasks. Certain metalloproteinases can also exhibit an inhibitory effect on tumorigenesis through an effect on angiogenesis. Matrilysin, stromelysin-1, and murine macrophage elastase (MME, MMP-12) are capable of cleaving plasminogen in vitro to yield angiostatin, which blocks endothelial cell proliferation. In tumor tissue, conversion of plasminogen to angiostatin is carried out by macrophage metalloproteinases. MME has been shown to be critical for the production of angiostatin, as MME-null macrophages are incapable of converting plasminogen to angiostatin (Cornelius et al, 1998) .
This study focuses on the effects of metalloproteinases on invasiveness. By comparing the types of active metalloproteinases released by invasive tumor cells to those produced by normal cells or noninvasive tumor cells, the particular metalloproteinases that contribute to tumor cell invasiveness in different types of cancer can be identi®ed. Matrigel invasion was used to assess invasiveness. The Matrigel assay revealed at least two components to invasiveness: inherent cell mobility, determined by the ability of cells to pass through uncoated ®lters; and ability to invade Matrigel. Of the three SCC cell lines, both FaDu and A431 showed greater mobility than HaCaT, the noninvasive, nontumorigenic keratinocyte line; however, only FaDu cells demonstrated signi®cantly greater invasion of Matrigel than HaCaT cells, indicating that cell mobility alone does not regulate invasiveness in SCC cells. Differences in cell mobility may re¯ect the different origins of the cell lines. HaCaT is a keratinocyte line and the A431 line is derived from an epidermal SCC, whereas FaDu and SiHa cells are derived from mucosal SCC. Batimastat-treated HaCaT, FaDu, and A431 cells were less active in passing through uncoated ®lters, suggesting that metalloproteinase activity contributes to cell mobility. Batimastat treatment, however, signi®cantly decreased Matrigel invasion only in FaDu cells, con®rming that invasiveness in this cell line requires metalloproteinase activity.
Because Batimastat does not act speci®cally on any particular metalloproteinase, expression of speci®c metalloproteinases was examined and compared among the four cell lines. No correlation was found between steady-state levels of mRNA for any particular metalloproteinase and invasiveness, indicating that regulation of invasiveness occurs at a post-transcriptional step, such as metalloproteinase synthesis or activation. Matrilysin and stromelysin-3 mRNA levels were similar in all four cell lines, but neither promatrilysin nor active matrilysin was detected in conditioned medium from HaCaT cells, whereas varying amounts of matrilysin and stromelysin-3 protein were found in medium from each of the four cell lines. Meade-Tollin et al found that matrilysin mRNA levels increased in noninvasive transformed HaCaT cells, but not in the invasive transformants. They further observed that secretion of matrilysin nonetheless increases in invasive transformants, and also concluded that post-transcriptional regulation of matrilysin expression contributes to the invasive phenotype (Meade-Tollin et al, 1998) .
A431 cells had the lowest steady-state levels of stromelysin-1 mRNA, but higher levels of stromelysin-1 protein in conditioned medium than HaCaT or SiHa cells. No difference was seen in levels of mRNA for TIMP-1 among the four cell lines, yet no TIMP-1 protein was found in conditioned medium from HaCaT cells. These results provide further support for post-transcriptional regulation of metalloproteinase and TIMP activity. TIMP-3 mRNA was present in all four cell lines, but no TIMP-3 protein was detected in conditioned medium from any cell line. This result was unexpected because the localization of matrilysin and TIMP-3 in skin is similar in vivo (Airola et al, 1998) . TIMP-3 binds strongly to extracellular matrix, however, and so may not have been extracted in conditioned medium (Woessner, 2001) . Alternatively, TIMP-3 may be not synthesized or secreted by these cell lines in vitro, or is produced in amounts that could not be detected by immunoblotting.
Matrilysin has been implicated in promoting tumorigenesis as well as invasiveness. In colon carcinoma cell lines, speci®c inhibition of matrilysin activity reduces both tumorigenicity and tumor invasiveness; however, transfection of matrilysin into cells that do not express the enzyme increased tumorigenicity but not invasiveness (Witty et al, 1994) . Thus, whereas matrilysin does not drive invasiveness in these cell types, it nonetheless contributes to invasion and metastasis in colon carcinoma. In our study, media from FaDu and A431 cells, the cell lines with greatest cell mobility, contained the highest amounts of gelatinase A, promatrilysin, and active matrilysin. No matrilysin was detected by immunoblotting in medium from HaCaT cells. Similar results were observed in transformed HaCaT cells: little or no matrilysin or gelatinase A was released into the medium by nontransformed cells, and the greatest amounts of these two enzymes were found in medium from transformed cells with an invasive, SCC phenotype (Bachmeier et al, 2000) . Therefore, matrilysin and gelatinase A appear to function in tumorigenesis and cell mobility, and contribute to, but do not trigger invasiveness in SCC cells.
Gelatinase B mRNA is expressed by tumor cells at the interface between tumor and stromal cells in SCC, but is not expressed by tumor cells in BCC or by normal skin cells (Pyke et al, 1992; Tsukifuji et al, 1999) . Immunoblotting experiments revealed that HaCaT cells secrete the greatest amount of active gelatinase B, whereas the enzyme is barely detectable in medium from the SCC cell lines. Others have used zymography to show that HaCaT and transformed HaCaT cells secrete gelatinase B, but they did not demonstrate a correlation between invasiveness and gelatinase B secretion. (Meade-Tollin et al, 1998; Bachmeier et al, 2000) . Within our experimental system, active gelatinase B secretion does not correlate with SCC invasiveness, as medium from the invasive cell line, FaDu, contained the least amount of active gelatinase B.
The most notable difference among the four cell lines was the release of active stromelysin-1 only by FaDu cells. Active stromelysin-1 could not be detected in conditioned medium from HaCaT, SiHa, or A431 cells. Bachmeier et al also detected weak production of prostromelysin-1 by HaCaT cells. In the transformed HaCaT cells, invasive cells produced much greater amounts of active stromelysin-1 than benign cells (Bachmeier et al, 2000) . In vivo, keratinocytes in normal skin do not express stromelysin-1, but expression is stimulated by wounding (Windsor et al, 1993; Saarialho-Kere et al, 1994) . In SCC, stromelysin-1 expression is associated with advanced pathology and metastasis (Muller et al, 1991; Kusukawa et al, 1996; Tsukifuji et al, 1999) . Stromelysin-1 also affects both tumorigenesis and invasiveness in some cancer cells. In stromelysin-1-transfected mammary epithelial cells, stromelysin-1 induction leads to phenotypic changes characteristic of tumor cells (Lochter et al, 1997; Sternlicht et al, 2000) . In DMBA-TPA-induced SCC in mouse skin, stromelysin-1 expression in tumor cells is coincident with the epithelial-to-mesenchymal transition that yields invasive, metastatic tumor cells (Wright et al, 1994) . Stromelysin-1 can activate matrilysin and cleave E-cadherin, releasing a soluble Ecadherin fragment that blocks E-cadherin function Noe È et al, 2000) . Thus, in addition to digesting extracellular matrix, active stromelysin-1 can enhance basal lamina degradation by matrilysin and facilitate invasion and metastasis by disrupting cell± cell and cell±matrix attachment. Active stromelysin-1 accordingly plays a key role in invasiveness, and our results suggest that activation of stromelysin-1 is an important regulatory step for invasiveness in SCC cells.
FaDu cells also released substantially greater amounts of stromelysins 2 and 3 into conditioned medium than the other cell lines. Both enzymes were barely detectable in SiHa medium, and stromelysin-3 was weakly detected in HaCaT and A431 medium. Because stromelysin-2 secretion was greatest in medium from HaCaT and FaDu cells, production of this metalloproteinase does not correlate with invasiveness. SCC tissue also expresses stromelysin-2 mRNA, which is transcribed in vivo by epithelial and tumor cells, but expression of this metalloproteinase is associated with tissue in¯ammation rather than tumor cell invasiveness in skin cancer (Kerkela È et al, 2001) . Stromelysin-2 can activate matrilysin and gelatinase B, however, and may contribute to tumor invasiveness through these enzymes (Nakamura et al, 1998) . Although stromelysin-3 secretion was greatest in the invasive cell line, FaDu, this metalloproteinase does not digest matrix proteins and is unlikely to play a direct role in invasiveness (Murphy et al, 1993; Pei and Weiss, 1995) . Instead, stromelysin-3 appears to foster the growth of tumors by blocking cell death and promoting implantation of malignant epithelial cells (Masson et al, 1998; Boulay et al, 2001) .
Stromelysin-3 mRNA is expressed in head and neck SCC, but not in normal tissues from the head and neck. In SCC tissue, stromelysin-3 mRNA and protein was found only in ®broblasts surrounding invasive cancer cells and not in tumor cells, suggesting a paracrine effect on tumor cells (Muller et al, 1993; Thewes et al, 1998) . We have demonstrated stromelysin-3 production in HaCaT and SCC cell lines, however, and Bachmeier et al have shown that this metalloproteinase is expressed by HaCaT and transformed HaCaT cell lines (Bachmeier et al, 2000) . Similarly, in skin cancer tissue, gelatinase A mRNA is expressed by stromal cells adjacent to tumor nodules in SCC and BCC, but is not expressed by tumor cells (Pyke et al, 1992; Tsukifuji et al, 1999 ), yet SCC cell lines produce gelatinase A in vitro. Normal keratinocytes do not synthesize stromelysin-1 in vivo, but HaCaT cells in vitro do produce stromelsyin-1 (Windsor et al, 1993; Saarialho-Kere et al, 1994) . Paracrine regulatory factors present in tissue are likely to explain the difference between stromelysin-3 and gelatinase A expression by cell lines in vitro and cells in vivo.
Cell-associated labeling for matrilysin, stromelysin-1, and TIMP-1 appeared to increase in mitotic cells, particularly in metaphase. The apparent increase may result from a change in shape as cells round up for cell division. Alternatively, these results may indicate a correlation between cell cycling and metalloproteinase or TIMP expression. Henriet et al have shown that plating melanoma cells on collagen I elevates expression of p27 KIP1´, and arrests the cells in G1 of the cell cycle (Henriet et al, 1999) . TIMP-1 localization to the nucleus has also been shown to be cell-cycle dependent in gingival ®broblasts (Zhao et al, 1998) . Therefore it is not unreasonable to hypothesize an association between metalloproteinase activity and the cell cycle. Nuclear localization of TIMP-1 was also observed in HaCaT cells in this study. Whereas precise phases of the cell cycle were not distinguished in these assays, nuclear localization of TIMP-1 was seen in HaCaT cells at all time points after removal of aphidicolin and was pronounced in aphidicolin-blocked cells that arrest in G1 (data not shown). Less dramatic nuclear expression of TIMP-1 was also observed in SiHa cells. Because neither of these two cell lines was able to invade Matrigel, it can be speculated that TIMP-1 has a nuclear function that affects cell mobility and invasiveness.
This study is not intended to be a comprehensive examination of the role of all known metalloproteinases in invasiveness. It is also limited to an in vitro model system. Other metalloproteinases may also play important roles in various aspects of tumorigenesis in vivo, including invasiveness. For example, the recently described collagenase-3 (MMP-13) can also degrade basement membrane components and may function in invasiveness. In head and neck SCC in vivo, collagenase-3 mRNA is expressed by tumor cells found on the leading edge of the tumor that are in contact with stromal ®broblasts (Johansson et al, 1997) . In laryngeal SCC, collagenase-3 expression correlates with overexpression of gelatinase A and MT-1-MMP, suggesting a cooperative effect of these enzymes on tumor progression (Cazorla et al, 1998) . We hope that our results on the expression of stromelysins and matrilysin in invasive SCC cell lines will stimulate further research on the functions of stromelysin-1 and other metalloproteinases in tumor cell invasiveness, and on the mechanisms through which these enzymes facilitate tumor cell invasion and metastasis in vivo.
